Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) - SPOCS
Study identifier:D3461R00001
ClinicalTrials.gov identifier:NCT03189875
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS): Prospective observational cohort of patients with moderate-to-severe SLE to characterize cross-sectional and longitudinal disease activity, treatment patterns and effectiveness, outcomes and comorbidities, healthcare resource utilization, and the impact of SLE on quality of life by type I interferon expression
Medical condition
Systemic Lupus Erythematosus
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
830
Study type
Observational
Age
18 Years - 130 Years
Date
Study Start Date: 28 Jun 2017
Primary Completion Date: 18 Nov 2022
Study Completion Date: 18 Nov 2022
Study design
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2024 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Observation Cohort of patients with moderate-to-severe SLE | Other: Standard of Care Participants will be followed as per local routine clinical practice Other Name: N/A |
